Furthermore, gene interactions between cuproptosis regulators (e.g., FDX1, DLAT) and ferroptosis regulators (e.g., GPX4, SLC7A11) emphasize their interaction, highlighting potential therapeutic strategies that target mitochondrial vulnerabilities in cancers (210). Here, SLC7A11 is linked to cancer.